Group One Trading, L.P. Sesen Bio, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.49 - $0.61 $33,825 - $42,108	-69,031 Reduced 16.6%	346,859 $211,000
Q3 2022 Nov 09, 2022	BUY	$0.0 - $0.93 $0 - $55,944	60,155 Added 16.91%	415,890 $177,000
Q2 2022 Aug 11, 2022	SELL	$0.38 - $0.89 $14,051 - $32,910	-36,978 Reduced 9.42%	355,735 $288,000
Q1 2022 May 12, 2022	SELL	$0.58 - $0.86 $228,149 - $338,291	-393,362 Reduced 50.04%	392,713 $237,000
Q4 2021 Feb 11, 2022	BUY	$0.73 - $1.28 $325,502 - $570,744	445,894 Added 131.08%	786,075 $641,000
Q3 2021 Nov 12, 2021	BUY	$0.77 - $4.91 $172,373 - $1.1 Million	223,862 Added 192.46%	340,181 $270,000
Q2 2021 Aug 10, 2021	SELL	$2.18 - $4.66 $134,074 - $286,599	-61,502 Reduced 34.59%	116,319 $537,000
Q1 2021 May 12, 2021	BUY	$1.3 - $3.24 $158,039 - $393,883	121,569 Added 216.11%	177,821 $462,000
Q4 2020 Feb 10, 2021	SELL	$1.01 - $1.77 $3,961 - $6,941	-3,922 Reduced 6.52%	56,252 $76,000
Q3 2020 Nov 12, 2020	BUY	$0.67 - $1.4 $39,569 - $82,682	59,059 Added 5296.77%	60,174 $84,000
Q2 2020 Aug 13, 2020	SELL	$0.52 - $0.87 $13,416 - $22,446	-25,800 Reduced 95.86%	1,115 $1,000
Q1 2020 May 13, 2020	BUY	$0.39 - $1.03 $251 - $665	646 Added 2.46%	26,915 $15,000
Q4 2019 Feb 10, 2020	BUY	$0.89 - $1.5 $11,270 - $18,994	12,663 Added 93.07%	26,269 $27,000
Q3 2019 Nov 12, 2019	SELL	$1.04 - $1.51 $3,146 - $4,567	-3,025 Reduced 18.19%	13,606 $16,000
Q2 2019 Aug 09, 2019	SELL	$0.95 - $2.46 $18,269 - $47,308	-19,231 Reduced 53.63%	16,631 $25,000
Q1 2019 May 13, 2019	SELL	$0.69 - $1.47 $12,558 - $26,755	-18,201 Reduced 33.67%	35,862 $37,000
Q4 2018 Feb 06, 2019	BUY	$0.96 - $2.04 $51,900 - $110,288	54,063 New	54,063 $77,000

Others Institutions Holding SESN

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Sesen Bio, Inc.

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

More about SESN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account